Sage Journals: Discover world-class research

Abstract

Keywords

contrast induced nephropathy carotid artery stenosis biomarkers

Get full access to this article

View all access options for this article.

References

Kelesoglu

Yilmaz

Elcik

, et al. C-reactive protein to albumin ratio as a predictor of contrast-induced nephropathy after carotid angiography. Angiology. 2024;75(1):90-97.

Kelesoglu

Yilmaz

Elcık

, et al. Systemic immune inflammation index: a novel predictor of contrast-induced nephropathy in patients with non-ST segment elevation myocardial infarction. Angiology. 2021;72(9):889-895.

Levy

Viscoli

Horwitz

. The effect of acute renal failure on mortality: a cohort analysis. JAMA. 1996;275(19):1489-1494.

Yalcinkaya

Karacali

Ilhan

Yarlioglues

. Relation between serum uric acid to albumin ratio and severity of chronic coronary artery disease. Angiology. 2024;75(4):386-393.

Çağdaş

Rencüzoğullari

Karakoyun

, et al. Assessment of relationship between C-reactive protein to albumin ratio and coronary artery disease severity in patients with acute coronary syndrome. Angiology. 2019;70(4):361-368.

Satilmis

Karabulut

. Value of C-reactive protein/albumin ratio in predicting the development of contrast-induced nephropathy in patients with non-ST elevation myocardial infarction. Angiology. 2020;71(4):366-371.

Şaylık

Çınar

Akbulut

Selçuk

. Serum uric acid to albumin ratio can predict contrast-induced nephropathy in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Angiology. 2023;74(1):70-78.

Kanal

Şeyda Kanal

Yakut

, et al. CRP albumin ratio may predict no reflow in patients undergoing percutaneous coronary intervention for saphenous vein graft stenosis. Angiology. 2023;74(1):55-61.

Çınar

Şaylık

Hayıroğlu

, et al. The association of serum uric acid/albumin ratio with no-reflow in patients with ST elevation myocardial infarction. Angiology. 2023;74(4):381-386.

10.

Vogel

Acevedo

Appelman

, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet. 2021;397(10292):2385-2438.

11.

Piepoli

Hoes

Agewall

, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Kardiol Pol. 2016;74(9):821-936.